docetaxel anhydrous has been researched along with daphnetin in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (daphnetin) | Trials (daphnetin) | Recent Studies (post-2010) (daphnetin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 159 | 0 | 117 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | daphnetin (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 7.67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Góralczyk, A; Wróblewska-Łuczka, P; Łuszczki, JJ | 1 |
1 other study(ies) available for docetaxel anhydrous and daphnetin
| Article | Year |
|---|---|
Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs.
Topics: Cisplatin; Coumarins; Cytostatic Agents; Docetaxel; Epirubicin; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mitoxantrone; Vemurafenib | 2023 |